Table 1. Socio-demographic and clinical characteristics of the studied asthma children (n=1077).

*Data are presented by n (%) and mean±SD.

**The number and percent exceeded 1077 (100%) as one patient may present with more than one manifestation.

SABA: short-acting beta agonist; ICS: inhaled corticosteroids; LABA: long-acting beta-agonist

Characteristics*		n (%)
Age in years; mean±SD (range)		6.1±3.0 (1-14)
Age in categories	<5 years	401 (37.2)
	5-12 years	676 (62.8)
Sex	Male	644 (59.8)
	Female	433 (40.2)
Nationality	Saudi	1009 (93.7)
	Non-Saudi	68 (6.3)
Asthma manifestation**	Shortness of breath	632 (58.7)
	Cough	650 (60.4)
	Chest tightness	459 (42.6)
	wheezing	528 (49.0)
Number of controller medications for asthma	SABA	797 (64.7)
	SABA-ICS	275 (25.5)
	SABA-LABA	57 (5.3)
	SABA-LABA ICS	48 (4.5)
Relief after SABA use	Yes	850 (78.9)
	No	227 (21.1)
Use of systematic corticosteroid	Yes	261 (24.2)
	No	816 (75.8)
Associated co-morbidities	Yes	45 (4.1%)
	No	1032 (95.9)
Family history of asthma/allergy	Yes	748 (69.4)
	No	329 (30.6)
Flu vaccination	Yes	515 (47.8)
	No	562 (52.2)